“Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease” (2025) SciELO Preprints [Preprint]. doi:10.1590/SciELOPreprints.12615.